Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THULITE: BI 1815368 in Centre-involved Diabetic Macular Edema
NCT06962839Phase 2Recruiting
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2025
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of BI 1815368 in diabetic macular edema (DME), sponsored by Boehringer Ingelheim. Started Jun 2025; status: recruiting.
02
Drugs
BI 1815368
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT06962839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06962839.